Transparency Market Research is Published new Market
Report " Nanomedicine
Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and
Oncology Applications) - Global Industry Analysis, Size, Share,Growth, Trends
and Forecast, 2013 - 2019," .The
market for nanomedicine was valued at USD 78.54 billion in 2012 and is expected
to reach a value of USD 177.60 billion in 2019, growing at a CAGR of 12.3% from
2013 to 2019.
Browse
the full report with complete TOC: http://www.transparencymarketresearch.com/nanomedicine-market.html
The advent of new applications and technology in the
field of nanomedicine will be one of the major growth factors for the global
nanomedicine market. In addition, increase of funding aimed at boosting the
research activities pertaining to nanomedicine by the government as well as
private institutions will expedite the process of commercialization of new
products and hence will drive the market. Other driving factors include rising
base of geriatric population, presence of high unmet medical needs and rising
worldwide incidences of chronic diseases.
The global nanomedicine market by applications was
dominated by the oncology market with a market share of approximately 38.0% in
2012 on account of the presence of high number of commercialized products in
this segment. Development of nanomedicine products enabling drugs crossing
blood brain barrier and targeting the tumor in brain and at other sites in the
body will prove to be a significant future growth driver for this market.
However, the global cardiovascular market for
nanomedicine is the fastest growing application segment. Factors such as the
presence of large patient prevalence coupled with rising demand for
nanotechnology enabled drugs and devices catering to this segment, attribute to
its high growth rate.
North America dominated the market in 2012 and is
expected to maintain its market position till 2019. However, theAsia-Pacific
market is estimated to grow at a faster pace (CAGR of 14.6% from 2013 to
2019).Europe is expected to grow at a relatively higher rate compared to North
America owing to constantly improving regulatory framework and the presence of
an extensive product pipeline portfolio.
Some of the key players in the global nanomedicine
market include GE Healthcare, Merck & Co Inc., Abbott Laboratories, Pfizer
Inc., Nanosphere Inc., Mallinckrodt plc, Teva Pharmaceutical Industries Ltd.,
Sigma-Tau Pharmaceuticals Inc., Celgene Corporation, Novavax, Inc.; Life
Technologies, MagArray, Inc., Gilead Sciences Inc. and others.
The global nanomedicine market is categorized into the following
segments:
Nanomedicine
Market by Application
·
Neurology
·
Cardiovascular
·
Anti-Inflammatory
·
Anti-Infectives
·
Oncology
·
Others
Nanomedicine
Market by Geography
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
(RoW)
Browse more market research reports: Transparency Market Research
0 comments:
Post a Comment